2 Small-Cap Biotech IPOs You Should Know About

While there were some relatively well-known businesses in the recent batch of IPOs, investors might be intrigued by two small-cap biotech stocks that are flying under the radar: molecular data mining pioneer Personalis (NASDAQ:PSNL) and the early-stage immuno-oncology company NextCure (NASDAQ:NXTC). Both companies are developing technology platforms catching the eyes of deep-pocketed customers and partners.